CompletedPhase 4

Benzydamine in Sore Throat Pain Relief (BePaiR Study)

Hungary356 participantsStarted 2020-08-13

Plain-language summary

The aim of this study is to generate new clinical data about the speed of relief provided by a single application of Benzydamine hydrochloride 0,3% oromucosal spray vs Benzydamine hydrochloride 3 mg lozenges mint flavour.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Presence of at least one symptom of URTI in the previous 24 h on the URTI questionnaire;
✓. Sore throat pain intensity score ≥ 60 mm on Sore Throat Pain Intensity Scale (STPIS);
✓. A score ≥ 5 on Tonsillo-Pharingytis Assessment (TPA);

What they're measuring

Percentage of responders at 2 min

Timeframe: 2 minutes

Trial details

NCT IDNCT04941976

SponsorAziende Chimiche Riunite Angelini Francesco S.p.A

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2021-06-30

View on ClinicalTrials.gov More Acute Sore Throat trials